Transcriptional activities of estrogen receptor alpha and beta in yeast properties of raloxifene

Biochemical Pharmacology

Volumn 62, Issue 7, 2001, Pages 953-961

  Jisa, Elisabeth ^a   Dornstauder, Eva ^a   Ogawa, Sumito ^b   Inoue, Sathoshi ^b   Muramatsu, Masami ^b   Jungbauer, Alois ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Agonist; Antagonist; BIACORE; Human estrogen receptor and ; Raloxifene; Transcription

Indexed keywords

DNA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LIGAND; MONOMER; RALOXIFENE; TESTOSTERONE;

ANALYTIC METHOD; ARTICLE; BINDING AFFINITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIMERIZATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; ESTROGEN RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; IMMOBILIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; TRANSACTIVATION; YEAST;

ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; RALOXIFENE; RECEPTORS, ESTROGEN; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0035479366     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00731-6     Document Type: Article

References (38)

1. The molecular pharmacology of SERMs
2. Estrogen receptor and the SERM concept
3. Menopausal estrogen replacement therapy and breast cancer
4. Targeted antiestrogens to prevent breast cancer
5. Estrogen receptor as a target for the prevention of breast cancer
6. Mechanisms for tamoxifen resistance in breast cancer: Possible role of tamoxifen metabolism
7. Tamoxifen in premenopausal patients with metastatic breast cancer: A review
8. The effects of tamoxifen on the uterus
9. Pharmacokinetics of raloxifene and its clinical application
10. Molecular basis of agonism and antagonism in the oestrogen receptor
11. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist
12. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
13. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
14. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists
15. Activation of the human estrogen receptor by estrogenic and antiestrogenic compounds in Saccharomyces cerevisiae: A positive selection system
16. Estrogen receptor ligands modulate its interaction with DNA
17. Ubiquitin-metallothionein fusion protein expression in yeast
18. Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli
19. Agonistic and synergistic activity of tamoxifen in a yeast model system
20. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro
21. A short polypeptide marker sequence useful for recombinant protein identification and purification
22. Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists
23. An intracellular expression system for yeast using ubiquitin-Flag-fusions
24. The human oestrogen receptor functions in yeast
25. Regulation of human estrogen receptor by phytoestrogens in yeast and human cells
26. Monitoring of estrogen mimics by a recombinant yeast assay: Synergy between natural and synthetic compounds?
27. An estrogen receptor basis for raloxifene action in bone
28. Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity
29. Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex
30. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha
31. Cloning and characterization of human estrogen receptor beta isoforms
32. A comparison of transcriptional activation by ER alpha and ER beta
33. Estrogen receptor interaction with co-activators and co-repressors*
34. Nuclear receptor coactivators and corepressors
35. Diverse signaling pathways modulate nuclear receptor recruitment of N- CoR and SMRT complexes
36. Nuclear receptor coactivators
37. Environmental estrogens induce transcriptionally active estrogen receptors dimers in yeast: Activity potentiated by the coactivator RIP140
38. ER beta: Identification and characterization of a novel human estrogen receptor